Belloy en France, France

Stéphanie Graf

This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Teva Sante. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stéphanie Graf. Retrieved from https://idiyas.com/inventor/stéphanie-graf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stéphanie Graf: Innovator in Optical Enantiomers

Introduction

Stéphanie Graf is a notable inventor based in Belloy en France, FR. He has made significant contributions to the field of pharmaceuticals, particularly in the development of optical enantiomers. His work has led to advancements that are crucial for the preparation of specific drug forms.

Latest Patents

Stéphanie Graf holds 1 patent for a process related to the preparation of crystalline forms of optical enantiomers of modafinil. This invention pertains to a polymorphic form of (−)-modafinil, which produces a powder X-ray diffraction spectrum with intensity peaks corresponding to interplanar spacings of about 8.54, 4.56, and 3.78 Å. This innovative process enhances the efficiency and effectiveness of modafinil formulations.

Career Highlights

Throughout his career, Stéphanie has worked with prominent companies in the pharmaceutical industry, including Teva Santé. His expertise in the field has allowed him to contribute to various projects that focus on drug development and optimization.

Collaborations

Stéphanie Graf has collaborated with notable professionals such as Olivier Neckebrock and Laurent Courvoisier. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his work.

Conclusion

Stéphanie Graf's contributions to the field of optical enantiomers exemplify the impact of innovative thinking in pharmaceuticals. His patent and collaborations highlight the importance of teamwork in advancing scientific knowledge and improving drug formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…